FOLD
Amicus Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$14.49
+0.00%Leverage
- Debt / equity
- 1.76x
- Net debt / equity
- 0.98x
- Debt / assets
- 0.51x
- Debt / EBITDA
- 8.98x
- Net debt / EBITDA
- 5.00x
Liquidity & coverage
- Current ratio
- 2.84x
- Quick ratio
- 1.88x
- Cash ratio
- 1.23x
- Interest coverage
- 0.71x
- EBITDA / interest
- 1.17x
- Working capital
- $438.3M
Cash & dividend
- FCF / debt
- 0.06x
- Cash flow / debt
- 0.07x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025